Literature DB >> 1281570

Posttransplant donor-specific T-lymphocytotoxic antibody in liver transplant patients with a positive crossmatch.

M Kobayashi1, A Yagihashi, R Manez, S Takaya, K Noguchi, A Konno, Y Kita, Y Yoshida, K Terasawa, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1281570      PMCID： PMC3005770     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis.

Authors:  K Nakamura; A Yagihashi; Y Iwaki; S Takaya; G G Hartman; N Murase; O Bronsther; R Manez; J J Fung; S Iwatsuki
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors.

Authors:  S Takaya; O Bronsther; Y Iwaki; K Nakamura; K Abu-Elmagd; A Yagihashi; A J Demetris; M Kobayashi; S Todo; A G Tzakis
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939
  2 in total
  2 in total

1.  Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.

Authors:  Jacqueline G O'Leary; Hugo Kaneku; Anthony J Demetris; John D Marr; S Michelle Shiller; Brian M Susskind; Glenn W Tillery; Paul I Terasaki; Göran B Klintmalm
Journal:  Liver Transpl       Date:  2014-01-02       Impact factor: 5.799

Review 2.  Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Authors:  Antonio Cuadrado; David San Segundo; Marcos López-Hoyos; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.